Form 4: Inogen Director Acquires Shares
Insider Transaction Filing
Kevin M. King, a Director at Inogen Inc., acquired 28,081 shares of common stock through a restricted stock unit award.
Summary
- Kevin M. King, a Director at Inogen Inc., acquired 28,081 shares of common stock on June 5, 2026.
- The acquisition was made through a restricted stock unit (RSU) award.
- These RSUs are subject to vesting conditions, including continued service and a one-year anniversary of the grant date or the day prior to the next Annual Meeting of Stockholders.
- Following this transaction, Mr. King beneficially owns 104,966 shares of common stock.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it represents a standard equity award to a director rather than an open-market purchase, but still indicates continued alignment of management and shareholder interests.
Positives
- Director acquisition of shares can signal confidence in the company's future prospects.
- The acquisition of 28,081 shares by a director indicates continued commitment to the company.
Future Outlook
The vesting of the restricted stock unit award is contingent upon the reporting person's continued service, with vesting occurring on the earlier of the one-year anniversary of the grant date or the day prior to the Issuer's next Annual Meeting of stockholders.
Industry Context
StockSavvy.ai notes that insider transactions, particularly share acquisitions by directors, are often viewed by the market as a positive signal of management's belief in the company's intrinsic value and future growth potential within the medical device sector.
Stakeholder Impact
- Shareholders: The acquisition by a director can be interpreted as a positive signal of confidence in the company's performance and future prospects, potentially influencing investor sentiment.
Next Steps
- Vesting of restricted stock unit award based on continued service and specified vesting schedule.
Key Dates
| Date | Description |
|---|---|
| 06/05/2026 | Transaction Date for acquisition of common stock. |
| 06/09/2026 | Date of signature for the filing. |
Keywords
Inogen Inc, INGN, Form 4, Insider Transaction, Restricted Stock Unit, Director, Share Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.